Iptakalim, a novel ATP-sensitive potassium channel opener, inhibits pulmonary arterial smooth muscle cell proliferation by downregulation of PKC-α

Journal of Biomedical Research

Volumn 25, Issue 6, 2011, Pages 392-401

  Zuo, Xiangrong ^a   Zong, Feng ^a   Wang, Hui ^b   Wang, Qiang ^a   Xie, Weiping ^a   Wang, Hong ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b No 81 Hospital of PLA   (China)

Author keywords

Hypoxia; Iptakalim; Proliferation; Protein ki nase C (PKC ); Pulmonary arterial smooth muscle cells (PASMCs); Pulmonary hypertension

Indexed keywords

GLIBENCLAMIDE; IPTAKALIM; POTASSIUM CHANNEL; PROTEIN KINASE; PROTEIN KINASE C ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; LUNG ARTERY PRESSURE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAT; SMOOTH MUSCLE FIBER;

EID: 84455172412     PISSN: 16748301     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1674-8301(11)60052-3     Document Type: Article

References (40)

1. Hopkins N, McLoughlin P The structural basis of pul-monary hypertension in chronic lung disease: Remodel-ling, rarefaction or angiogenesis?. J Anat 2002, 201:335-348.
2. Galie N, Hoeper MM, Humbert M, Torbicki A, Vach-iery JL, Barbera JA, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009, 34:1219-1263.
3. Weitzenblum E, Chaouat A, Canuet M, Kessler R Pul-monary hypertension in chronic obstructive pulmonary disease and interstitial lung diseases. Semin Respir Crit Care Med 2009, 30:458-470.
4. Voelkel NF, Tuder RM Hypoxia-induced pulmonary vascular remodeling: A model for what human disease?. J Clin Invest 2000, 106:733-738.
5. Stenmark KR, Fagan KA, Frid MG Hypoxia-induced pulmonary vascular remodeling: Cellular and molecular mechanisms. Circ Res 2006, 99:675-691.
6. Cooper AL, Beasley D Hypoxia stimulates proliferation and interleukin-1alpha production in human vascular smooth muscle cells. Am J Physiol 1999, 277:H1326-H1337.
7. Lu SY, Wang DS, Zhu MZ, Zhang QH, Hu YZ, Pei JM Inhibition of hypoxia-induced proliferation and collagen synthesis by vasonatrin peptide in cultured rat pulmo-nary artery smooth muscle cells. Life Sci 2005, 77:28-38.
8. Schultz K, Fanburg BL, Beasley D Hypoxia and hy-poxia-inducible factor-1alpha promote growth factor-induced proliferation of human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 2006, 290:H2528-H2534.
9. Dempsey EC, McMurtry IF, O'Brien RF Protein kinase C activation allows pulmonary artery smooth muscle cells to proliferate to hypoxia. Am J Physiol 1991, 260:L136-L145.
10. Dempsey EC, Newton AC, Mochly-Rosen D, Fields AP, Reyland ME, Insel PA, et al. Protein kinase C isozymes and the regulation of diverse cell responses. Am J Phys-iol Lung Cell Mol Physiol 2000, 279:L429-L438.
11. Konopatskaya O, Poole AW. Protein kinase Calpha: Disease regulator and therapeutic target. Trends Pharmacol Sci;31:8-14.
12. Dempsey EC, Cool CD, Littler CM Lung disease and PKCs. Pharmacol Res 2007, 55:545-559.
13. Zhu Z, Xu Y, Zou H, Zhang Z, Ni W, Chen S Effects of puerarin on pulmonary vascular remodeling and pro-tein kinase C-alpha in chronic cigarette smoke exposure smoke-exposed rats. J Huazhong Univ Sci Technolog Med Sci 2008, 28:27-32.
14. Dempsey EC, Frid MG, Aldashev AA, Das M, Stenmark KR Heterogeneity in the proliferative response of bo-vine pulmonary artery smooth muscle cells to mitogens and hypoxia: importance of protein kinase C. Can J Physiol Pharmacol 1997, 75:936-944.
15. Xu Y, Stenmark KR, Das M, Walchak SJ, Ruff LJ, Dempsey EC Pulmonary artery smooth muscle cells from chronically hypoxic neonatal calves retain fetal-like and acquire new growth properties. Am J Physiol 1997, 273:L234-L245.
16. Do e Z, Fukumoto Y, Takaki A, Tawara S, Ohashi J, Nakano M, et al. Evidence for Rho-kinase activation in patients with pulmonary arterial hypertension. Circ J 2009, 73:1731-1739.
17. Bonnet S, Archer SL Potassium channel diversity in the pulmonary arteries and pulmonary veins: Implications for regulation of the pulmonary vasculature in health and during pulmonary hypertension. Pharmacol Ther 2007, 115:56-69.
18. + channels of vascular smooth muscle cells. J Cardiovasc Electrophysiol 2003, 14:94-103.
19. ATP channels in vas-cular smooth muscle. Clin Exp Pharmacol Physiol 2002, 29:312-316.
20. ATP channels in human pulmonary artery smooth muscle cells and their modulation by growth. Am J Respir Cell Mol Biol 2002, 26:135-143.
21. Guibert C, Marthan R, Savineau JP Modulation of ion channels in pulmonary arterial hypertension. Curr Pharm Des 2007, 13:2443-2455.
22. Wang H, Tang Y, Wang L, Long CL, Zhang YL ATP-sensitive potassium channel openers and 2,3-dimethyl-2-butylamine derivatives. Curr Med Chem 2007, 14:133-155.
23. ATP channel opener, on pulmonary vascu-lar remodeling in hypoxic rats. Life Sci 2004, 75:2065-2076.
24. ATP channel opener, in cultured rabbit pulmonary arterial smooth muscle cells. Eur J Pharmacol 2005, 511:81-87.
25. ATP channel. Vascul Pharmacol 2008, 48:92-99.
26. Tan X, Liu YJ, Li JC, Pan JQ, Sun WD, Wang XL Ac-tivation of PKCalpha and pulmonary vascular remodel-ling in broilers. Res Vet Sci 2005, 79:131-137.
27. Barman SA Potassium channels modulate canine pul-monary vasoreactivity to protein kinase C activation. Am J Physiol 1999, 277:L558-L565.
28. Presberg KW, Dincer HE Pathophysiology of pulmo-nary hypertension due to lung disease. Curr Opin Pulm Med 2003, 9:131-138.
29. Stenmark KR, McMurtry IF Vascular remodeling ver-sus vasoconstriction in chronic hypoxic pulmonary hy-pertension: A time for reappraisal?. Circ Res 2005, 97:95-98.
30. Yu TZ, Ma CT Effects of angiotensin-converting en-zyme and angiotensin II on hypoxia-induced proliferation of cultured intra-pulmonary artery smooth muscle cells. Acta Pharmacol Sin 2000, 21:381-384.
31. Nakashima S Protein kinase C alpha (PKCalpha): Regu-lation and biological function. J Biochem 2002, 132:669-675.
32. Itoh H, Yamamura S, Ware JA, Zhuang S, Mii S, Liu B, et al. Differential effects of protein kinase C on human vascular smooth muscle cell proliferation and migration. Am J Physiol Heart Circ Physiol 2001, 281:H359-H370.
33. Rodrigo GC, Standen NB ATP-sensitive potassium channels. Curr Pharm Des 2005, 11:1915-1940.
34. + channels in smooth muscle. J Physiol 2006, 572:617-624.
35. Dumas JP, Bardou M, Goirand F, Dumas M Hypoxic pulmonary vasoconstriction. Gen Pharmacol 1999, 33:289-297.
36. + channels regulate resting potential of pulmonary arterial smooth muscle cells. Am J Physiol 1992, 262:H916-H920.
37. Oka M, Morris KG, McMurtry IF Nip-121 is more ef-fective than nifedipine in acutely reversing chronic pul-monary hypertension. J Appl Physiol 1993, 75:1075-1080.
38. ATP channel openers: Structure-activity relationships and therapeutic potential. Med Res Rev 2004, 24:213-266.
39. Wang H, Long C, Duan Z, Shi C, Jia G, Zhang Y A new ATP-sensitive potassium channel opener protects endothelial function in cultured aortic endothelial cells. Cardiovasc Res 2007, 73:497-503.
40. Long CL, Qin XC, Pan ZY, Chen K, Zhang YF, Cui WY, et al. Activation of ATP-sensitive potassium chan-nels protects vascular endothelial cells from hypertension and renal injury induced by hyperuricemia. J Hy-pertens 2008, 26:2326-2338.